sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Jul-2015 14:16
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 951-975 out of 1085.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>

Public Release: 14-Nov-2013
Prize will expand use of life-saving neonatal device in Africa
A low-cost device that Rice University bioengineering students invented to help premature babies breathe more easily will be rolled out to teaching hospitals in three African nations, thanks to a $400,000 award from pharmaceutical giant GlaxoSmithKline (GSK) and London-based charity Save the Children. The technology, which is known as "bubble CPAP," earned the top prize in GSK and Save the Children's inaugural Healthcare Innovation Award program.
Save the Children, GlaxoSmithKline

Contact: Jade Boyd
Rice University

Public Release: 14-Nov-2013
Cell, Host & Microbe
Bleeding symptom leads scientists to intracellular trafficker's role in virus propagation
Vermont researchers find a new important clue to how deadly rodent-borne viruses harness ERGIC-53 to ensure their reproductive success.
National Institutes of Health

Contact: Jennifer Nachbur
University of Vermont

Public Release: 14-Nov-2013
Lancet Infectious Diseases
Low-dose treatment may block malaria transmission
Lower doses of the antimalarial drug primaquine are as effective as higher doses in reducing malaria transmission, according to a study published today in Lancet Infectious Diseases by London School of Hygiene & Tropical Medicine researchers.
Wellcome Trust, Bill & Melinda Gates Foundation

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 14-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
Drug trial for top parasitic killer of the Americas: Mixed results, new evidence to improve therapy
According to results of the first-ever Phase 2 clinical trial in Bolivia, the drug candidate E1224 showed good safety and was effective at clearing the parasite causing Chagas disease, but had little to no sustained efficacy one year after treatment. On the other hand, standard therapy, benznidazole, was effective long term but continued to be associated with side effects. The results point to alternative dosing regimens and possible combination therapies to improve patient care.
Wellcome Trust

Contact: Oliver Yun
Drugs for Neglected Diseases Initiative

Public Release: 14-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
The Lancet
New malaria vaccines roadmap targets next generation products by 2030
The world should aim to have vaccines which reduce malaria cases by 75 percent, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 Malaria Vaccine Technology Roadmap, launched today. This new target comes in addition to the original 2006 Roadmap's goal of having a licensed vaccine against Plasmodium falciparum malaria, the most deadly form of the disease, for children under 5 years of age in sub-Saharan Africa by 2015.

Contact: Dr. Vasee Moorthy

Public Release: 14-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
New research reveals dengue fever mystery in 2 US cities both exposed to risk
As dengue fever continues to spread from Key West north into the Florida mainland, it remains a mystery as to why this dangerous mosquito-borne illness is not yet common around Tucson, Arizona -- even though outbreaks routinely occur in nearby Mexico and mosquitoes that can carry dengue are now common in the state, according to a new research presented today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Preeti Singh
Burness Communications

Public Release: 14-Nov-2013
2013 AAPS Annual Meeting and Exposition
Novel microbicide gel for vagina and rectum shows potential for HIV prevention
Researchers developed a first-of-its-kind microbicide gel formulation that shows promise for safe vaginal and rectal administration to prevent the sexual transmission of human immunodeficiency virus. This research is being presented at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

Contact: Dana Korsen
American Association of Pharmaceutical Scientists

Public Release: 12-Nov-2013
Dr. Robert Gallo named first Homer & Martha Gudelsky Distinguished Professor in Medicine
Robert C. Gallo, M.D., has been named the first Homer & Martha Gudelsky Distinguished Professor in Medicine at the University of Maryland School of Medicine during a ceremony November 7. The ceremony also honored the Gudelsky Family Foundation for their extraordinary generosity in supporting the Institute of Human Virology at the University of Maryland School of Medicine in Baltimore, MD.

Contact: Nora Grannell
University of Maryland Medical Center

Public Release: 12-Nov-2013
Fifth Annual World Pneumonia Day marks successes and challenges in tackling #1 killer of children
Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. A new report issued today found gradual increases in access to vaccines, treatment, and other interventions in the 15 countries with the highest numbers of child deaths from pneumonia and diarrhea.

Contact: Julie Younkin
International Vaccine Access Center

Public Release: 12-Nov-2013
2013 AAPS Annual Meeting and Exposition
CONRAD presents new technology combining contraception, HIV and herpes simplex virus-2 prevention
CONRAD Head of drug delivery, Meredith Clark, Ph.D., today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition in San Antonio, Texas.CONRAD's deputy director of clinical research, Marianne Callahan, will also present information on MPTs at the International Conference on Family Planning in Addis Ababa, Ethiopia.
US Agency for International Development

Contact: Annette Larkin

Public Release: 11-Nov-2013
Canadian Medical Association Journal
Some 'healthy' vegetable oils may actually increase risk of heart disease
Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and Health Canada should reconsider cholesterol-lowering claims on food labelling, states an analysis in CMAJ (Canadian Medical Association Journal): Replacing saturated animal fats with polyunsaturated vegetable oils has become common practice because they can reduce serum cholesterol levels and help prevent heart disease.

Contact: Michael Kennedy
University of Toronto

Public Release: 10-Nov-2013
Nature Chemical Biology
How zinc starves lethal bacteria to stop infection
Australian researchers have found that zinc can 'starve' one of the world's most deadly bacteria by preventing its uptake of an essential metal.

Contact: Dr Christopher McDevitt
University of Adelaide

Public Release: 10-Nov-2013
Griffith joins the fight against pneumonia
Advancing the fight against pneumonia is the focus of a new online scholarly journal launched by Griffith University ePress.
Griffith University ePress

Contact: Louise Durack
Griffith University

Public Release: 8-Nov-2013
SSI and Aeras announce initiation of Phase I/IIa clinical trial for TB vaccine candidate
Statens Serum Institut and Aeras announce the initiation of a Phase I/IIa clinical trial in South Africa for a candidate tuberculosis (TB) vaccine designed to protect people, especially those latently infected with TB, from developing active TB disease.

Contact: Annmarie Leadman

Public Release: 7-Nov-2013
Biochemical Journal
Blocking the active site of thiolase
Scientists at the University of Oulu, Finland, and at the HZB break new ground for drug discovery research in the fight against sleeping sickness Scientists at the University of Oulu, Finland, and at the Helmholtz Center Berlin have shown the way to new directions in drug development against African sleeping sickness and other tropical parasitic infections.

Contact: Dr. Manfred Weiss
Helmholtz-Zentrum Berlin für Materialien und Energie

Public Release: 7-Nov-2013
Japanese fund to invest in promising technology against malaria, tuberculosis and Chagas disease
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

Contact: Katy Lenard
GHIT Fund -- Global Health Innovative Technology Fund

Public Release: 7-Nov-2013
PLOS Neglected Tropical Diseases
Climate may play a role in the distribution and prevalence of trachoma
High temperatures and low rainfall are important factors which influence the occurrence and severity of the active stages of trachoma -- the most common cause of infectious blindness -- according to a new study publishing Nov. 7, 2013, in PLOS Neglected Tropical Diseases.

Contact: Katie Steels

Public Release: 5-Nov-2013
PLOS Medicine
Syphilis screening and treatment in pregnancy may be cost-effective in sub-Saharan Africa
Screening and treating pregnant women in sub Saharan Africa for syphilis may be a cost-effective use of resources, according to a study published in this week's PLOS Medicine. The study by Mohammed Lamorde and colleagues, suggests that screening pregnant women for syphilis usingimmunochromatographic strip point-of-care tests, and subsequent treatment with benzathine penicillin, could efficiently reduce the burden of congenital syphilis.

Contact: Fiona Godwin

Public Release: 4-Nov-2013
Population Council awarded flagship family planning implementation science project by USAID
The Population Council has been granted a cooperative agreement from the US Agency for International Development's Office of Population and Reproductive Health. The award supports the project "Strengthening Family Planning/Reproductive Health Programming through Implementation Science (EVIDENCE)," which will generate and synthesize evidence to strengthen and contribute to the scale-up of high-quality family planning and reproductive health services in USAID priority countries.
US Agency for International Development

Contact: Sasha Gruber
Population Council

Public Release: 4-Nov-2013
Environmental Science & Technology
Virginia Tech researchers explore natural way to displace harmful germs from household plumbing
Microbes in tap water are mostly harmless, with a few exceptions. A Virginia Tech research team is investigating four harmful pathogens that have been documented in tap water and suggest a natural, probiotic way to deal with dangerous germs.

Contact: John Pastor
Virginia Tech

Public Release: 3-Nov-2013
Nature Genetics
Singapore scientists expose molecular secrets of bile duct cancers from different countries
A Singapore-led scientific team discovers critical genes in bile duct cancers from different parts of the world. New molecular insights point to potentially different treatment regimens for the same cancer type depending on underlying genetic alterations.

Contact: Rachel Tan

Public Release: 31-Oct-2013
PLOS Neglected Tropical Diseases
Leading cause of heart disease ignored in North America's poorest communities
A leading cause of heart disease remains overlooked in North America's most impoverished communities, researchers said today in an editorial published in PLOS Neglected Tropical Diseases. Chagas disease has rendered a heavy health and economic toll, yet insufficient political and medical support for gathering specific data, providing diagnosis and treatment, and developing new tools has impeded much-needed breakthroughs.

Contact: Deborah Elson

Public Release: 31-Oct-2013
PLOS Neglected Tropical Diseases
Study tracks risk of VL exposure in Brazil's urban areas
The factors involved in VL transmission are poorly understood, especially in urban and densely populated counties. Dr. Mariangela Carneiro, Federal University of Minas Gerais, Brazil, and colleagues conducted studies on urbanization and expansion of VL in Belo Horizonte, capital of Minas Gerais State.

Contact: Mariangela Carneiro

Public Release: 31-Oct-2013
PLOS Neglected Tropical Diseases
Microsatellite DNA analysis reveals genetic change of P. vivax in Korea, 2002-2003
Malaria is one of the major infectious diseases transmitted by mosquitos, with enormous impact on quality of life. According to World Health Organization figures, as of 2010 there were over 219 million reported cases of malaria with an estimated 660,000 deaths. Plasmodium vivax, which is the second most prevalent species of the human malaria parasite, is widely distributed around the world especially in Asia, Melanesia, the Middle East, South and Central America. 2.85 billion people worldwide live at risk of the infection in 2009.

Contact: Ryouhei Nishigaya

Public Release: 30-Oct-2013
International Journal of Molecular Sciences
BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
A review article by researchers at Boston University School of Medicine suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer.

Contact: Gina Orlando
Boston University Medical Center

Showing releases 951-975 out of 1085.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>